These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4114014)

  • 1. 2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase.
    Arnesen H; Fagerhol MK
    Scand J Clin Lab Invest; 1972 May; 29(3):259-63. PubMed ID: 4114014
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
    Gormsen J; Tidstrom B; Feddersen C; Ploug J
    Acta Med Scand; 1973; 194(3):191-8. PubMed ID: 4583532
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of clofibrate on components of the fibrinolytic enzyme system.
    Ogston D; Bennett NB; Crawford GP; Douglas AS
    Atherosclerosis; 1972; 16(2):273-6. PubMed ID: 4117793
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiplasmin, antitrypsin and antithrombin activity of alpha-2-macroglobulin].
    Steinbuch M; Blatrix C; Josso F
    Transfusion (Paris); 1967; 10(1):103-20. PubMed ID: 6048644
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis in pre-eclamptic toxaemia of pregnancy.
    Wardle EN; Menon IS
    Br Med J; 1969 Jun; 2(5657):625-7. PubMed ID: 5798476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Dec; 108(12):727-60 passimf. PubMed ID: 4911753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemotherapy with an antithrombin-antiplasmin concentrate of human plasma (alpha2-macroglobulin concentrate)].
    Marx R; Matis P
    Med Welt; 1969 Dec; 50():2718-22. PubMed ID: 4190097
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of urokinase in acute myocardial infarction].
    Bokarev IN; Makolkin VI; Butorov VN; Terekhov VN; Kuznetsov VA
    Kardiologiia; 1988 Nov; 28(11):36-40. PubMed ID: 3068399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1-antitrypsin, an inhibitor for thrombin and plasmin.
    Gans H; Tan BH
    Clin Chim Acta; 1967 Jul; 17(1):111-7. PubMed ID: 4166651
    [No Abstract]   [Full Text] [Related]  

  • 11. Human alpha2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma.
    de Vonne TL; Mouray H
    Clin Chim Acta; 1978 Nov; 90(1):83-5. PubMed ID: 82495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
    Fischer M
    Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
    [No Abstract]   [Full Text] [Related]  

  • 13. The inhibition of tissue plasminogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects.
    Thorsen S
    Scand J Clin Lab Invest; 1973 Jan; 31(1):51-9. PubMed ID: 4687777
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Samama M; Conard J; Verdy E; van Dreden P; Nguyen G; Combrisson A; Acar J
    Drugs; 1987; 33 Suppl 3():268-74. PubMed ID: 3315605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic inhibitors in human retroplacental blood.
    Astedt B
    Acta Obstet Gynecol Scand; 1974; 53(3):227-9. PubMed ID: 4136151
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of the content of serum alpha2-macroglobulin and the condition of the trypsin-trypsin inhibitor system in different forms of ischemic heart disease].
    Movshovich BL; Karpova LP
    Kardiologiia; 1975 Feb; 15(2):133-5. PubMed ID: 47408
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolysis for acute myocardial infarction: the future is here and now.
    Armstrong PW; Collen D; Antman E
    Circulation; 2003 May; 107(20):2533-7. PubMed ID: 12777317
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypofibrinolysis in acute myocardial infarction (author's transl)].
    Bruhn HD; Jipp P; Okoye S; Oltmann A
    Med Klin; 1974 Nov; 69(47):1951-5. PubMed ID: 4444662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparin increases platelet aggregation and inhibits fibrinolysis, especially in primary hypertriglyceridemia and after myocardial infarction].
    Jastrzebska M; Chełstowski K; Torbus-Lisiecka B; Pieczul-Mróz J; Wesołowska T; Wira D
    Kardiol Pol; 1992 Sep; 37(9):136-41. PubMed ID: 1479769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.